Holen Sie sich die Stockscreener-App
22.36
1.89%
-0.425
Schlusskurs vom Vortag:
$22.79
Offen:
$22.77
24-Stunden-Volumen:
404.70K
Relative Volume:
0.44
Marktkapitalisierung:
$2.82B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$29.73M
KGV:
126.07
EPS:
0.1774
Netto-Cashflow:
$162.20M
1W Leistung:
-4.00%
1M Leistung:
-6.22%
6M Leistung:
-8.59%
1J Leistung:
-2.19%
1-Tages-Spanne:
$22.30
$22.98
1-Wochen-Bereich:
$22.30
$23.55
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.35 | 2.87B | 2.12B | 29.73M | 162.20M | 0.1774 |
VEEV
Veeva Systems Inc
|
158.01 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.08 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.70 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.83 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
53.27 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (PRVA) Movement - Stock Traders Daily
Privia Health Group, Inc. 8-K Filing May 2026: Executive Compensation Vote Results and Company Information - Minichart
Privia Health Group shareholders approve all proposals at annual meeting - Investing.com
Privia Health (PRVA) director receives 8,463 restricted stock units as equity award - Stock Titan
Privia Health (PRVA) director receives 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 RSUs in equity grant - Stock Titan
Privia Health (PRVA) director McCarthy granted 8,463 RSUs and updates holdings - Stock Titan
Privia Health Group (PRVA) director awarded 8,463 restricted stock units - Stock Titan
Privia Health Group (PRVA) director Jaewon Ryu granted 8,463 restricted stock units - Stock Titan
Director at Privia Health (PRVA) receives 8,463 RSU grant as board compensation - Stock Titan
Privia Health (PRVA) director Francis Soistman files initial Form 3 with no holdings - Stock Titan
Privia Health (NASDAQ: PRVA) holders approve directors, pay and auditor - Stock Titan
PRVA Stock Price, Quote & Chart | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
A Look At Privia Health Group (PRVA) Valuation After Q1 Results And Maintained 2026 Revenue Guidance - simplywall.st
BMO Capital Initiates Coverage of Privia Health Group (PRVA) with Outperform Recommendation - MSN
Privia Health Group CEO & Director Parth Mehrotra Sells 47% Of Holding - simplywall.st
What to expect from Privia Health’s (PRVA) Q1 earnings - MSN
Discipline and Rules-Based Execution in PRVA Response - Stock Traders Daily
Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point - simplywall.st
Statutory Profit Doesn't Reflect How Good Privia Health Group's (NASDAQ:PRVA) Earnings Are - Yahoo Finance
Privia Health Group Insider Sold Shares Worth $2,731,898, According to a Recent SEC Filing - Moomoo
Privia Health CFO David Mountcastle sells $76,501 in stock By Investing.com - Investing.com Australia
Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 105,439 Shares of Stock - MarketBeat
Privia Health CEO sells over $2.7m in company stock - Investing.com
Privia Health CEO sells over $2.7m in company stock By Investing.com - Investing.com Nigeria
[Form 4] Privia Health Group, Inc. Insider Trading Activity - Stock Titan
Privia Health CFO David Mountcastle sells $76,501 in stock - Investing.com UK
Privia Health Group (NASDAQ:PRVA) CFO Sells $76,501.00 in Stock - MarketBeat
Privia Health (PRVA) CFO tax-driven sale of 3,385 shares disclosed - Stock Titan
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue - Investing.com India
Privia Health (PRVA) Q1 2026 Earnings Transcript - AOL.com
TradingKey - TradingKey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
[144] Privia Health Group, Inc. SEC Filing - Stock Titan
A Look At Privia Health Group (PRVA) Valuation After Mixed Recent Share Performance - Sahm
Parth Mehrotra sells PRVA shares, multiple March 2026 transactions (PRVA) - Stock Titan
Affiliate files Form 144 to sell 3,385 shares (PRVA) - Stock Titan
Why Privia Health Group Shares Are Sinking Today - TipRanks
Privia Health Group, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-05-09 - Seeking Alpha
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2026 Earnings Call Transcript - Insider Monkey
Privia Health Earnings Call Highlights Profitable Growth - The Globe and Mail
Privia Health Group Q1 Earnings Call Highlights - TradingView
Privia Health Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Privia Health Q1 2026 slides show operational strength, earnings disappoint By Investing.com - Investing.com Canada
Privia Health: Q1 Earnings Snapshot - theheraldreview.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.92%
1.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):